Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
Children's Clinic, St. Olavs Hospital, Trondheim, Norway.
JAMA Netw Open. 2021 Mar 1;4(3):e211420. doi: 10.1001/jamanetworkopen.2021.1420.
Individuals born preterm have increased risk of mental health impairment compared with individuals born at term. The associations between preterm birth and attention-deficit/hyperactivity disorder and autism are well established; for depression, anxiety, psychotic and bipolar disorder, studies show divergent results.
To compare the prescription of psychotropic drugs in adolescence and young adulthood between those born preterm and those born at term.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used registry data to identify all Norwegians born after 23 weeks of completed gestation between 1989 and 1998. Included individuals were those without registered birth defects, alive at age 10 years, and with available maternal data. Individuals were followed up from 2004 to 2016. Psychotropic drug prescriptions received from age 10 to 23 years were compared between preterm groups and peers born at term. Individuals were compared with their siblings to control for shared family confounding. Data analyses were performed from August 2018 through February 2020.
Gestational age at birth (GA) was categorized in 4 groups: extremely preterm (GA, 23 weeks and 0 days to 27 weeks and 6 days), very preterm (GA, 28 weeks and 0 days to 31 weeks and 6 days), moderately or late preterm (GA, 32 weeks and 0 days to 36 weeks and 6 days), and full term (GA, 37 weeks and 0 days to 44 weeks and 6 days).
Prescriptions of psychotropic drugs (ie, prescriptions specifically of psychostimulants, antidepressants, anxiolytics, hypnotics or sedatives, or antipsychotics or prescriptions of any of these 5 drugs) among preterm groups were compared with prescriptions among peers born at term and among siblings.
Among 505 030 individuals (259 545 [51.4%] males; mean [SD] birth weight, 3533 [580] g), 762 individuals (0.2%) were extremely preterm, 2907 individuals (0.6%) were very preterm, 25 988 individuals (5.1%) were moderately or late preterm, and 475 373 individuals (94.1%) were full term. Individuals born preterm had increased risk of psychotropic drug prescription, with a dose-response association between GA and prescription. The extremely preterm group had higher rates of prescription for all drug types compared with peers born at term, with odds ratios from 1.7 (95% CI, 1.4-2.1) for antidepressants to 2.7 (95% CI, 2.1-3.4) for psychostimulants. The elevated odds of prescription of all types were less pronounced in the moderately to late preterm group, including odds ratios of 1.1 (95% CI, 1.0-1.1) for antidepressants and 1.2 (95% CI, 1.1-1.2) for psychostimulants. The increases in odds were smaller in the sibling comparison, and increases were not significant for several groups. For example, the OR for any prescription in the sibling analysis was 1.8 (95% CI, 1.2-2.8) in the very preterm group and 1.0 (95% CI, 0.9-1.1) in the moderately or late preterm group.
This cohort study found higher rates of prescription of psychotropic drugs throughout adolescence and young adulthood among individuals with all degrees of preterm birth compared with those born at term. These results provide further evidence for an increased risk of mental health impairment among individuals born preterm and suggest that this is not restricted to the most preterm groups.
与足月出生的个体相比,早产儿患心理健康障碍的风险增加。早产与注意力缺陷/多动障碍和自闭症的关联已得到充分证实;对于抑郁症、焦虑症、精神病和双相情感障碍,研究结果存在差异。
比较早产儿和足月出生儿在青少年和青年期使用精神药物的情况。
设计、地点和参与者:本队列研究使用登记数据,确定了 1989 年至 1998 年间在妊娠 23 周后出生的所有挪威人。纳入标准为:无登记出生缺陷、10 岁时存活且有可用的母亲数据。从 2004 年到 2016 年对个体进行随访。比较了早产儿组和足月出生儿从 10 岁到 23 岁期间的精神药物处方情况。个体与其兄弟姐妹进行比较,以控制共同的家庭混杂因素。数据分析于 2018 年 8 月至 2020 年 2 月进行。
出生时的胎龄(GA)分为 4 组:极早产儿(GA,23 周零 0 天至 27 周零 6 天)、非常早产儿(GA,28 周零 0 天至 31 周零 6 天)、中度或晚期早产儿(GA,32 周零 0 天至 36 周零 6 天)和足月(GA,37 周零 0 天至 44 周零 6 天)。
与足月出生的同龄人相比,早产儿组(专门为精神兴奋剂、抗抑郁药、抗焦虑药、催眠药或镇静剂或抗精神病药开具的处方,或这些 5 种药物中的任何一种开具的处方)的精神药物处方情况,以及与兄弟姐妹的处方情况。
在 505030 名个体(259545 名男性;平均[SD]出生体重为 3533[580]g)中,有 762 名(0.2%)是极早产儿,2907 名(0.6%)是非常早产儿,25988 名(5.1%)是中度或晚期早产儿,475373 名(94.1%)是足月。与足月出生的同龄人相比,早产儿有更高的精神药物处方风险,胎龄与处方之间存在剂量反应关系。与足月出生的同龄人相比,极早产儿组所有药物类型的处方率均较高,抗抑郁药的比值比为 1.7(95%CI,1.4-2.1),精神兴奋剂的比值比为 2.7(95%CI,2.1-3.4)。中度至晚期早产儿组中,所有类型药物处方的优势比都不那么明显,包括抗抑郁药的比值比为 1.1(95%CI,1.0-1.1)和精神兴奋剂的比值比为 1.2(95%CI,1.1-1.2)。在兄弟姐妹比较中,优势比的增加较小,并且几个组的增加并不显著。例如,在非常早产儿组中,任何处方的 OR 为 1.8(95%CI,1.2-2.8),在中度至晚期早产儿组中,OR 为 1.0(95%CI,0.9-1.1)。
本队列研究发现,与足月出生的个体相比,所有程度的早产儿在青少年和青年期使用精神药物的比例都更高。这些结果为早产儿心理健康受损风险增加提供了进一步的证据,并表明这种情况不仅局限于最早产的群体。